Page last updated: 2024-09-05

5-hydroxy-2-n,n-dipropylaminotetralin and ropinirole

5-hydroxy-2-n,n-dipropylaminotetralin has been researched along with ropinirole in 3 studies

Compound Research Comparison

Studies
(5-hydroxy-2-n,n-dipropylaminotetralin)
Trials
(5-hydroxy-2-n,n-dipropylaminotetralin)
Recent Studies (post-2010)
(5-hydroxy-2-n,n-dipropylaminotetralin)
Studies
(ropinirole)
Trials
(ropinirole)
Recent Studies (post-2010) (ropinirole)
4203637129243

Protein Interaction Comparison

ProteinTaxonomy5-hydroxy-2-n,n-dipropylaminotetralin (IC50)ropinirole (IC50)
D(2) dopamine receptorBos taurus (cattle)6.81

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonio, T; Dutta, AK; Ghosh, B; Kharkar, P; Reith, ME; Zhen, J1
Antonio, T; Dutta, AK; Ghosh, B; Reith, ME1
Antonio, T; Dutta, A; Ghosh, B; Gopishetty, B; Reith, M1

Other Studies

3 other study(ies) available for 5-hydroxy-2-n,n-dipropylaminotetralin and ropinirole

ArticleYear
Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Animals; Antiparkinson Agents; Benzothiazoles; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Free Radical Scavengers; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoquinolines; Locomotion; Mice; Parkinson Disease; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Structure-Activity Relationship; Thiazoles

2010
Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in sympto
    Journal of medicinal chemistry, 2010, Mar-11, Volume: 53, Issue:5

    Topics: Animals; Disease Models, Animal; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Iron Chelating Agents; Locomotion; Magnetic Resonance Spectroscopy; Male; Neuroprotective Agents; Oxyquinoline; Parkinson Disease; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship; Tetrahydronaphthalenes

2010
Further delineation of hydrophobic binding sites in dopamine D(2)/D(3) receptors for N-4 substituents on the piperazine ring of the hybrid template 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol.
    Bioorganic & medicinal chemistry, 2010, Aug-01, Volume: 18, Issue:15

    Topics: Binding Sites; Biphenyl Compounds; Cell Line; Humans; Hydrophobic and Hydrophilic Interactions; Piperazine; Piperazines; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes

2010
chemdatabank.com